Wire Stories
-
1.0KToshiba Releases 650V Super Junction Power MOSFETs in TOLL Package That Help Improve Efficiency of High Current Equipment
TOKYO–(BUSINESS WIRE)–Toshiba Electronic Devices & Storage Corporation (“Toshiba”) has launched 650V super junction power MOSFETs, TK065U65Z, TK090U65Z, TK110U65Z, TK155U65Z and TK190U65Z, in...
-
738
Allegro DVT Releases New Versions of its Encoder and Decoder IPs with Support for 12-bits Sample Size and 4:4:4 Chroma Format
GRENOBLE, France–(BUSINESS WIRE)–#12bits–Allegro DVT, the leading provider of video processing silicon IPs, today announced the release of new versions of its D3x0...
-
751
Zilliqa Capital Launches a New Approach to Grow Southeast Asian Financial Ecosystem
The firm will be led by Co-Founder and former CEO of Ether Capital, Michael H. Conn, alongside executives and thought leaders from...
-
701
Best�s Special Report: New Capital Bond Rules Will Help Thailand Insurers Unlock Additional Financing Source
SINGAPORE–(BUSINESS WIRE)–AM Best believes new regulations in Thailand allowing insurance companies to leverage insurance capital bonds as an alternative source of financing...
-
819
Sprinklr Announces New R&D Center in Singapore
Immediately hiring engineers for Research and Development Center to support continued business growth Leading brands in Asia Pacific � including Samsung, Gojek,...
-
669
Rio Tinto makes first sale of aluminium-scandium alloy for 3D printing
MONTREAL–(BUSINESS WIRE)–Rio Tinto has signed an agreement to provide a first commercial batch of high-performance aluminium-scandium alloy from its North American operations...
-
858
BeiGene Announces Presentation of Clinical and Preclinical Data at the AACR Annual Meeting 2021
CAMBRIDGE, Mass. & BEIJING–(BUSINESS WIRE)–$BGNE #BTKi–BeiGene, Ltd. (NASDAQ: BGNE; HKEX: 06160), a commercial-stage biotechnology company focused on developing and commercializing innovative medicines...
-
627
Humanigen Announces $80 Million Loan Facility from Hercules Capital
Company intends to use funds to support lenzilumab manufacturing and commercialization BURLINGAME, Calif.–(BUSINESS WIRE)–Humanigen, Inc. (Nasdaq: HGEN) (�Humanigen�), a clinical stage biopharmaceutical...
-
639
Humanigen Reports Fourth Quarter and Year-End 2020 Financial Results and Provides Corporate Update
Lenzilumab� clinical development program for COVID-19 advances from IND to completion of Phase 3 enrollment in fewer than 12 months Company completes...
-
571
Asia Pacific Aesthetic Medical Laser Systems Market Forecast to 2027: Market Opportunities with Increasing Awareness of Aesthetic Procedures – ResearchAndMarkets.com
DUBLIN–(BUSINESS WIRE)–The “Asia Pacific Aesthetic Medical Laser Systems Market Forecast to 2027 – COVID-19 Impact and Regional Analysis By Type, Application, and...
